Literature DB >> 9016644

Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.

C Pérez1, M Leng, J M Malinge.   

Abstract

In the reaction of the anticancer drug cis-diamminedichloroplatinum(II) (cis-DDP) with DNA, bifunctional intrastrand and interstrand cross-links are formed. In this work, we show that at 37 degrees C interstrand cross-links (ICL) are labile and rearrange into intrastrand cross-links. The ICL instability was first studied with a 10 base pairs (bp) double-stranded oligonucleotide containing a unique site-specific ICL resulting from chelation of the N7 position of two guanine residues on the opposite strands of DNA at the d(GC/GC) site by a cis-diammineplatinum(II) residue. The bonds between the platinum and the N7 of guanine residues within the interstrand adduct are cleaved. In 50 mM NaCl or NaClO4, this cleavage results in the formation of monofunctional adducts which subsequently form intrastrand cross-links. One cleavage reaction takes place per cross-linked duplex in either of both DNA strands. Whereas the starting cross-linked 10 bp duplex is hydrogen bonded, the two complementary DNA strands separate after the cleavage of the ICL. Under these conditions, the cleavage reaction is irreversible allowing its rate measurement (t1/2= 29+/-2 h) and closure of monofunctional adducts to intrastrand cross-links occurs within single-stranded DNA. Within a longer cross-linked oligonucleotide (20 bp), ICL are apparently more stable (t1/2= 120+/-12 h) as a consequense of monofunctional adducts closure back to ICL. We propose that the ICL cleavage is reversible in DNA and that these adducts rearrange finally into intrastrand cross-links. Our results could explain an 'ICL unhooking' in previously reported in vivo repair studies [Zhenet al. (1993)Carcinogenesis14, 919-924].

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016644      PMCID: PMC146515          DOI: 10.1093/nar/25.4.896

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

1.  How effective are chemical and biological sterilization indicators?

Authors:  P P Caporino
Journal:  J Healthc Mater Manage       Date:  1991 Jan-Feb

2.  Chemical probes of the conformation of DNA modified by cis-diamminedichloroplatinum(II).

Authors:  L Marrot; M Leng
Journal:  Biochemistry       Date:  1989-02-21       Impact factor: 3.162

3.  NMR solution structure of a DNA decamer containing an interstrand cross-link of the antitumor drug cis-diamminedichloroplatinum (II).

Authors:  F Paquet; C Pérez; M Leng; G Lancelot; J M Malinge
Journal:  J Biomol Struct Dyn       Date:  1996-08

Review 4.  Quantitative estimation of cisplatin-induced DNA interstrand cross-links and their repair in mammalian cells: relationship to toxicity.

Authors:  J J Roberts; F Friedlos
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

Review 5.  The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes.

Authors:  A Eastman
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

6.  Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA.

Authors:  M A Lemaire; A Schwartz; A R Rahmouni; M Leng
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

7.  Possible catalytic activity of DNA in the reaction between the antitumor drug cis-diamminedichloroplatinum(II) and the intercalator N-methyl-2,7-diazapyrenium.

Authors:  F Gaucheron; J M Malinge; A J Blacker; J M Lehn; M Leng
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

8.  The reaction of platinum(II) complexes with DNA. Kinetics of intrastrand crosslink formation in vitro.

Authors:  F Bernges; E Holler
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

9.  Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.

Authors:  A M Fichtinger-Schepman; J L van der Veer; J H den Hartog; P H Lohman; J Reedijk
Journal:  Biochemistry       Date:  1985-01-29       Impact factor: 3.162

10.  Formation of a DNA monofunctional cis-platinum adduct cross-linking the intercalating drug N-methyl-2,7-diazapyrenium.

Authors:  J M Malinge; M Sip; A J Blacker; J M Lehn; M Leng
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

View more
  4 in total

1.  Pt-bridges in various single-strand and double-helix DNA sequences. DFT and MP2 study of the cisplatin coordination with guanine, adenine, and cytosine.

Authors:  Matej Pavelka; Jaroslav V Burda
Journal:  J Mol Model       Date:  2006-09-20       Impact factor: 1.810

Review 2.  DNA interstrand crosslink repair in mammalian cells: step by step.

Authors:  Parameswary A Muniandy; Jia Liu; Alokes Majumdar; Su-ting Liu; Michael M Seidman
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-02       Impact factor: 8.250

3.  Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis.

Authors:  Milica Enoiu; Josef Jiricny; Orlando D Schärer
Journal:  Nucleic Acids Res       Date:  2012-07-18       Impact factor: 16.971

4.  Walking of antitumor bifunctional trinuclear PtII complex on double-helical DNA.

Authors:  Jaroslav Malina; Jana Kasparkova; Nicholas P Farrell; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2010-09-09       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.